Integrated Diagnostics Receives $47,250,000 Series B Funding

  • Feed Type
  • Date
    4/29/2014
  • Company Name
    Integrated Diagnostics
  • Mailing Address
    219 Terry Avenue North Seattle, WA 98109 USA
  • Company Description
    The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer’s through blood tests that can monitor tens to hundreds of disease markers simultaneously.
  • Website
    http://www.indidx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $47,250,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The mixed equity and debt investment will be used to further commercialize Xpresys, which launched in late 2013, and to develop additional proteomic blood tests using Indi’s technology platform.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.